TV News LIES

Sunday, Jun 24th

Last update05:20:13 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Prosthetic hand gets sense of touch with electronic 'skin'

Prosthetic hand get sonse of touchEngineers have developed an electronic "skin" that allows prosthetic hand users to perceive a real sense...

Theranos Founder and Former Chief Operating Officer Charged In Alleged Wire Fraud Schemes

Elizabeth Holmes of theranos indictedA federal grand jury has indicted Elizabeth A. Holmes and Ramesh “Sunny” Balwani, announced Acting United...

Prosthetic hand gets sense of touch with electronic 'skin'

Prosthetic hand get sonse of touchEngineers have developed an electronic "skin" that allows prosthetic hand users to perceive a real sense...

Frustrated AMA adopts sweeping policies to cut gun violence

AMA adopts sweeping policies against gunsWith frustration mounting over lawmakers' inaction on gun control, the American Medical Association on Tuesday pressed...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!